Search research articles
Contact Us
Filters
Showing results (11-20 of 113) with videos related to
Page
of 12
Sort By:
Ophthalmic Plastic and Reconstructive Surgery
|
June 6, 2017
Clinical Presentation and Anatomical Location of Orbital Plasmacytomas
Bradley A Thuro, Oded Sagiv, Roman Shinder, et al.
The Journal of Pain
|
May 1, 2012
Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty
Tito R Mendoza, Dhanalakshmi Koyyalagunta, Allen W Burton, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 7, 2023
Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors
Chia-Yu Chiu, Sairah Ahmed, Sheeba K Thomas, et al.
The Lancet. Haematology
|
December 4, 2018
Bortezomib, lenalidomide, and dexamethasone with panobinostat for front-line treatment of patients with multiple myeloma who are eligible for transplantation: a phase 1 trial
Elisabet E Manasanch, Jatin J Shah, Hans C Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 22, 2026
Analysis of Social Drivers of Health, Race, and Ethnicity With Survival in Myeloma Patients
Christen M Dillard, Ashwath Gurumurthi, Hans C Lee, et al.
BMC Cancer
|
February 15, 2018
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol
Sheeba K Thomas, Soung-Chul Cha, D Lynne Smith, et al.
Journal of Hematology & Oncology
|
February 7, 2013
Validation of the M. D. Anderson Symptom Inventory multiple myeloma module
Desiree Jones, Elisabeth G Vichaya, Xin Shelley Wang, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 2013
Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy
Elisabeth G Vichaya, Xin Shelley Wang, Jessica A Boyette-Davis, et al.
British Journal of Haematology
|
May 14, 2025
Phase I study of pomalidomide in relapsed or refractory Waldenström macroglobulinaemia
Karan L Chohan, Donna M Weber, Lei Feng, et al.
Leukemia
|
May 17, 2019
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
Marc S Raab, Sheeba K Thomas, Enrique M Ocio, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 113) with videos related to
Sort By:
Page
of 12
Ophthalmic Plastic and Reconstructive Surgery
|
June 6, 2017
Clinical Presentation and Anatomical Location of Orbital Plasmacytomas
Bradley A Thuro, Oded Sagiv, Roman Shinder, et al.
The Journal of Pain
|
May 1, 2012
Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty
Tito R Mendoza, Dhanalakshmi Koyyalagunta, Allen W Burton, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 7, 2023
Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors
Chia-Yu Chiu, Sairah Ahmed, Sheeba K Thomas, et al.
The Lancet. Haematology
|
December 4, 2018
Bortezomib, lenalidomide, and dexamethasone with panobinostat for front-line treatment of patients with multiple myeloma who are eligible for transplantation: a phase 1 trial
Elisabet E Manasanch, Jatin J Shah, Hans C Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 22, 2026
Analysis of Social Drivers of Health, Race, and Ethnicity With Survival in Myeloma Patients
Christen M Dillard, Ashwath Gurumurthi, Hans C Lee, et al.
BMC Cancer
|
February 15, 2018
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol
Sheeba K Thomas, Soung-Chul Cha, D Lynne Smith, et al.
Journal of Hematology & Oncology
|
February 7, 2013
Validation of the M. D. Anderson Symptom Inventory multiple myeloma module
Desiree Jones, Elisabeth G Vichaya, Xin Shelley Wang, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 2013
Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy
Elisabeth G Vichaya, Xin Shelley Wang, Jessica A Boyette-Davis, et al.
British Journal of Haematology
|
May 14, 2025
Phase I study of pomalidomide in relapsed or refractory Waldenström macroglobulinaemia
Karan L Chohan, Donna M Weber, Lei Feng, et al.
Leukemia
|
May 17, 2019
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
Marc S Raab, Sheeba K Thomas, Enrique M Ocio, et al.
Page
of 12